Molnupiravir, or Lagevrio, has been granted interim authorisation below the pandemic special accessibility route. (Merck & Co by means of Reuters file photograph) SINGAPORE — A next oral antiviral drug has been authorised for the procedure of moderate to average COVID-19 in people aged 18 a long time and above in Singapore, the Wellness Sciences […]
